EBEmma Barron

Emma Barron

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emma Barron has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Prevalence of multiple long-term conditions (multimorbidity) in England: a whole population study of over 60 million people

    by Jonathan Valabhji, Emma Barron, Adrian Pratt, Nasrin Hafezparast, Rupert Dunbar-Rees, Ellie Bragan Turner, Kate Roberts, Jacqueline Mathews, Robbie Deegan, Victoria Cornelius, et al.

    Objectives: To determine the prevalence of multiple long-term conditions (MLTC) at whole English population level, stratifying by age, sex, socioeconomic status and ethnicity. Design: A whole population study. Setting: Individuals registered with a general practice in England and alive on 31 March 2020. Participants: 60,004,883 individuals. Main outcome measures: MLTC prevalence, defined as two or more of 35 conditions derived from a number of national patient-level datasets. Multivariable logistic regression was used to assess the independent associations of age, sex, ethnicity and deprivation decile with odds of MLTC. Results: The overall prevalence of MLTC was 14.8% (8,878,231), varying from 0.9% (125,159) in those aged 0–19 years to 68.2% (1,905,979) in those aged 80 years and over. In multivariable regression analyses, compared with the 50–59 reference group, the odds ratio was 0.04 (95% confidence interval (CI): 0.04–0.04; p < 0.001) for those aged 0–19 years and 10.21 (10.18–10.24; p < 0.001) for those aged 80 years and over. Odds were higher for men compared with women, 1.02 (1.02–1.02; p < 0.001), for the most deprived decile compared with the least deprived, 2.26 (2.25–2.27; p < 0.001), and for Asian ethnicity compared with those of white ethnicity, 1.05 (1.04–1.05; p < 0.001). Odds were lower for black, mixed and other ethnicities (0.94 (0.94–0.95) p < 0.001, 0.87 (0.87–0.88) p < 0.001 and 0.57 (0.56–0.57) p < 0.001, respectively). MLTC for persons aged 0–19 years were dominated by asthma, autism and epilepsy, for persons aged 20–49 years by depression and asthma, for persons aged 50–59 years by hypertension and depression and for those aged 60 years and older, by cardiometabolic factors and osteoarthritis. There were large numbers of combinations of conditions in each age group ranging from 5936 in those aged 0–19 years to 205,534 in those aged 80 years and over. Conclusions: While this study provides useful insight into the burden across the English population to assist health service delivery planning, the heterogeneity of MLTC presents challenges for delivery optimisation.


  • Open Access

    Impact of the COVID ‐19 pandemic on new diagnoses of type 2 diabetes in England

    by Emma Barron, Kamlesh Khunti, Alison K. Wright, Darren M. Ashcroft, Matthew J. Carr, Martin K. Rutter, Jonathan Valabhji


  • Open Access

    Effectiveness of digital and remote provision of the Healthier You: NHS Diabetes Prevention Programme during the COVID‐19 pandemic

    by Emma Barron, Dominque Bradley, Soraya Safazadeh, Ben McGough, Chirag Bakhai, Bob Young, Kamlesh Khunti, Elizabeth Murray, Nick Wareham, Susan Jebb, et al.

    Aims: To assess weight change in the Healthier You: NHS Diabetes Prevention Programme (NHS DPP) delivered via video conferencing (remote) sessions or delivered via specific digital interventions through apps or websites, during the COVID‐19 pandemic compared to group‐based face‐to‐face interventions, pre‐pandemic.Methods: Prospectively collected national service‐level data relating to individuals with non‐diabetic hyperglycaemia (HbA1c 42–47 mmol/mol (6.0%–6.4%) or fasting plasma glucose 5.5–6.9 mmol/L) referred to the NHS DPP from June 2016 to March 2022.Results: Between March 2020 and March 2022, 335,961 people were referred to the programme and were offered a choice of remote or digital intervention. This was preceded by 556,793 people referred to the face‐to‐face programme between June 2016 and February 2022. Uptakes to intervention sessions were 47% for those offered a choice and 39% for face‐to‐face. Remote and digital participants were significantly younger (60 and 56 vs. 65 years) and heavier (86.1 kg and 91.0 kg vs. 84.1 kg) compared to face‐to‐face. Weight change was assessed for 42,407 remote, 7699 digital and 97,205 face‐to‐face participants with sufficient time to have finished the programme and no missing data. Mean weight losses for participants attending at least one intervention session were: 2.40 (2.36–2.44) kg, 2.59 (2.49–2.68) kg and 2.01 (1.98–2.04) kg for remote, digital and face‐to‐face participants respectively. Corresponding mean weight losses for those who completed the programme were: 3.24 (3.19–3.30) kg, 4.76 (4.60–4.92) kg and 3.04 (3.00–3.07) kg. There were no significant differences in weight change between interventions by ethnicity and deprivation.Conclusions: Weight losses achieved through remote and digital interventions were greater than those previously achieved through face‐to‐face interventions, without evidence of exacerbation of health inequalities.


  • Open Access

    Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England

    by Shivani Misra, Naomi Holman, Emma Barron, Peter Knighton, Justin Warner, Partha Kar, Bob Young, Jonathan Valabhji

    Introduction: We report contemporary age‐related prevalence, characteristics and care of children and young people with type 2 diabetes in England.Methods: Individuals with a recorded diagnosis of type 2 diabetes between January 2019 and March 2020 were identified from a whole population register. Age, sex, ethnicity, deprivation quintile, weight, HbA1cand receipt of the nine National Institute for Health & Care Excellence (NICE) recommended annual care processes were extracted from electronic clinical records and analysed by pre‐specified age bands.Results: In total, 122,780 (4.6%) of 2,642,435 individuals in England with type 2 diabetes were aged under 40 years, comprising; 650 (0.5%) under 16 years, 910 (0.7%) aged 16–18 years, 8245 (6.7%) aged 19–25 and 112,975 (92%) aged 26–39 years. Compared to people with type 2 diabetes aged above 40 years, young people were significantly more likely to be from minority ethnic groups: 51% under 16 years, 41% 16–18 years, 38% 19–25 years, 38% 26–39 years, 27% 40–59 years and 15% 60–79 years were of Black or Asian ethnicity. In addition, those aged under 40 years were more likely to be obese, women, to live in the most‐deprived socioeconomic areas and less likely to receive the NICE recommended annual care processes or achieve target HbA1c.Interpretation: The substantial number of people under 40 years of age with type 2 diabetes, are more likely to have characteristics associated with inequalities and are less likely to achieve HbA1ctargets and receive recommended care processes. These findings highlight the need to consider novel approaches to service provision for this high‐risk group.


  • Open Access

    Developing services to support the delivery of care to people with early‐onset type 2 diabetes

    by Shivani Misra, David Gable, Kamlesh Khunti, Emma Barron, Bob Young, Partha Kar, Jonathan Valabhji

    Early‐onset type 2 diabetes occurring in childhood or early adulthood carries a significant excess burden of microvascular diabetes complications, cardiovascular disease and premature death, compared to later onset type 2 diabetes along with adverse pregnancy outcomes in women of child‐bearing age. National audit data in England reveal that 122,780 individuals under the age of 40 years are currently living with type 2 diabetes, with an over‐representation of people from minority ethnicities and those in the most socioeconomically deprived quintiles. A diagnosis of type 2 diabetes earlier in life poses some unique challenges to healthcare providers that are not routinely encountered when type 2 diabetes presents later. These include; (1) the need to ensure correct diabetes classification in an age group that carries a higher probability of other types of diabetes, (2) overcoming difficulties in engaging with individuals who are of working age or in full‐time education, (3) appreciating and addressing the lower attainment of diabetes treatment targets and (4) proactively supporting women of child‐bearing age to optimise their future pregnancy outcomes through better preparation for pregnancy, including achieving optimum glycaemic control at the time of conception. Meanwhile, approaches to prevent type 2 diabetes in younger age groups are challenged by difficulties in identifying those at highest risk, by poorer attendance at lifestyle interventions to prevent or delay the onset of type 2 diabetes and by attenuation of associated weight loss in those that do attend. In this article, we discuss the importance of recognising and addressing the distinct challenges in delivering healthcare to those with early‐onset type 2 diabetes, the greater challenges in preventing type 2 diabetes at younger ages, and key components of strategies that might address these challenges to drive improvements in pregnancy outcomes, microvascular and cardiovascular outcomes.


  • Open Access

    Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study

    by Jamie Anne Dolan Ross, Emma Barron, Ben McGough, Jonathan Valabhji, Kerry Daff, Jenny Irwin, William E Henley, Elizabeth Murray

    Introduction ‘Healthier You’, the National Health Service (NHS) diabetes prevention programme (DPP) offers adults in England at high risk of type 2 diabetes (T2DM) an evidence-based behavioral intervention to prevent or delay T2DM onset. This study assesses the impact of a pilot digital stream of the DPP (DDPP) on glycated hemoglobin (HbA1c) and weight. Research design and methods A service evaluation employing prospectively collected data in a prospective cohort design in nine NHS local pilot areas across England. Participants were adults with non-diabetic hyperglycemia (NDH) (HbA1c 42–47 mmol/mol or fasting plasma glucose 5.5–6.9 mmol/L) in the 12 months prior to referral. The DDPP comprised five digital health interventions (DHI). Joint primary outcomes were changes in HbA1c and weight between baseline and 12 months. HbA1c and weight readings were recorded at referral (baseline) by general practices, and then at 12-month postregistration. Demographic data and service variables were collected from the DHI providers. Results 3623 participants with NDH registered for the DDPP and of these, 2734 (75%) were eligible for inclusion in the analyses. Final (12-month) follow-up data for HbA1c were available for 1799 (50%) and for weight 1817 (50%) of registered participants. Mean change at 12 months was −3.1 (−3.4 to −2.8) kg, pConclusions Participation in the DDPP was associated with clinically significant reductions in weight and HbA1c. Digital diabetes prevention can be an effective and wide-reaching component of a population-based approach to addressing type 2 diabetes prevention.


  • Open Access

    Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study

    by Emma Barron, Shivani Misra, Emma English, W Garry John, Michael Sampson, Max O Bachmann, Julian Barth, Nick Oliver, K G M M Alberti, Chirag Bakhai, et al.

    Introduction To report the observations of point-of-care (POC) glycated hemoglobin (HbA1c) testing in people with non-diabetic hyperglycemia (NDH; HbA1c 42–47 mmol/mol (6.0%–6.4%)), applied in community settings, within the English National Health Service Diabetes Prevention Programme (NHS DPP). Research design and methods A service evaluation assessing prospectively collected national service-level data from the NHS DPP, using data from the first referral received in June 2016–October 2018. Individuals were referred to the NHS DPP with a laboratory-measured HbA1c in the NDH range and had a repeat HbA1c measured at first attendance of the program using one of three POC devices: DCA Vantage, Afinion or A1C Now+. Differences between the referral and POC HbA1c and the SD of the POC HbA1c were calculated. The factors associated with the difference in HbA1c and the association between POC HbA1c result and subsequent attendance of the NHS DPP were also evaluated. Results Data from 73 703 participants demonstrated a significant mean difference between the referral and POC HbA1c of −2.48 mmol/mol (−0.23%) (t=157, pConclusion POC HbA1c testing in community settings was associated with significantly lower HbA1c values when compared with laboratory-measured referrals. Acknowledging effects of regression to the mean, we found that these differences were also associated with POC method, location, individual patient factors and time between measurements. Compared with POC HbA1c values in the NDH range, normoglycemic POC HbA1c values were associated with lower subsequent intervention attendance.


  • Open Access

    The Healthier You: NHS Diabetes Prevention Programme: digital modes of delivery engage younger people

    by B. McGough, E. Murray, L. Brownlee, E. Barron, J. Smith, J. Valabhji


  • Open Access

    Progress of the Healthier You: NHS Diabetes Prevention Programme: referrals, uptake and participant characteristics

    by E. Barron, R. Clark, R. Hewings, J. Smith, J. Valabhji

    Aims: To describe early progress of the Healthier You: NHS Diabetes Prevention Programme, a behavioural intervention designed to prevent or delay onset of Type 2 diabetes in people in England already identified to be at high risk, to assess numbers of referrals received by Programme providers and the proportion that attended the initial assessment, and to identify the factors associated with attendance rates.Methods: These analyses examine the data for referrals received between June 2016 and March 2017.Results: There were 43 603 referrals received, 16% higher than expected. Of those referred, 49% attended the initial assessment, higher than the 40% modelled uptake. Of those referred, there was no significant difference in uptake by sex (P=0.061); however, attendance per 100 000 population varied significantly by sex, age group, ethnicity and deprivation; it was significantly lower for men (PPPP<0.001) such that attendance rates were significantly higher in the most deprived quintile vs the least deprived quintile for Asian, Afro‐Caribbean, mixed and other ethnic groups but not significantly different for white European ethnic groups.Conclusion: The analyses show that referral numbers and percentage uptake are in excess of prior modelled values. Characteristics of attendees suggest that the programme is reaching those who are both at greater risk of developing Type 2 diabetes and who typically access healthcare less effectively.